In this infographic, ISR explores what US patients know about Biologic and Biosimilar Medicines, who they’re consulting to make decisions, and how a small amount of information can affect that.
Date: September 3, 2013
- Public Knowledge, Perceptions, and Intentions for Biologic and Biosimilar Medicines
- Biosimilar Primer: US Primary Care Physicians' Attitudes, Beliefs, and Intentions
- Primer: Biosimilars in the US Oncology Market